Literature DB >> 2442742

Digestive enzymes and protease inhibitors in plasma from patients with acute pancreatitis.

M A Dubick, G Mar, A D Mayer, A P Majumdar, M J McMahon, M C Geokas.   

Abstract

The plasma levels of certain digestive enzymes and protease inhibitors were determined in 40 patients with severe acute pancreatitis diagnosed as gallstone-induced (GP), alcoholic (AP), or idiopathic (IP). On admission, plasma levels of amylase and immunoreactive cationic trypsin(ogen) (IRCT) and elastase 2 (IRE 2) were found to be 50 +/- 10 ng/ml, 340 +/- 64 ng/ml, and 190 +/- 15 ng/ml, respectively, in all groups of patients. These enzymes levels remained high for the first 2 days following hospitalization and then decreased, although amylase and IRCT levels remained elevated above normal values throughout the study period (2 weeks). In general amylase and IRCT were lower in patients with concomitant ascites, pancreatic pseudocysts, or abscesses, and higher in patients who died, as compared to the pancreatitis group as a whole. In these patients, levels of immunoreactive alpha 1-protease inhibitor (alpha 1-PI) and alpha 2-macroglobulin (alpha 2-M) remained relatively constant at the lower end of the normal range throughout the study period. Inhibitor levels in plasma were unaffected by the etiology of pancreatitis or the occurrence of complications. A similar trend was seen with plasma levels of lysosomal hydrolases. The results indicate that in this group of patients, plasma levels of pancreatic digestive enzymes were reflective of the clinical features and severity of the disease, as well as the time following the acute attack that brought the patient to the hospital.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442742     DOI: 10.1097/00006676-198703000-00011

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Pancreatitis from intestinal reflux--again?

Authors:  M Blackstone
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

2.  Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.

Authors:  M Ventrucci; R Pezzilli; L Gullo; L Platé; G Sprovieri; L Barbara
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

3.  Impaired mononuclear phagocyte function in patients with severe acute pancreatitis: evidence from studies of plasma clearance of trypsin and monocyte phagocytosis.

Authors:  M Larvin; D J Alexander; S F Switala; M J McMahon
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

4.  alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis.

Authors:  L Umans; L Serneels; L Overbergh; L Stas; F Van Leuven
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  Serum amylase and lipase concentrations and lipase/amylase ratio in assessment of etiology and severity of acute pancreatitis.

Authors:  R Pezzilli; P Billi; M Miglioli; L Gullo
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

6.  Histopathologic correlates of serum amylase activity in acute experimental pancreatitis.

Authors:  J Schmidt; K Lewandrowski; C Fernandez-del Castillo; U Mandavilli; C C Compton; A L Warshaw; D W Rattner
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.